{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:51:46Z","timestamp":1788951106426,"version":"build-2803163510"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["94-01-57-27939"],"award-info":[{"award-number":["94-01-57-27939"]}]},{"DOI":"10.13039\/501100005014","name":"Avicenna Research Institute","doi-asserted-by":"publisher","award":["960511-036"],"award-info":[{"award-number":["960511-036"]}],"id":[{"id":"10.13039\/501100005014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00262-019-02350-8","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T02:02:16Z","timestamp":1559700136000},"page":"1039-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["PLAC1: biology and potential application in cancer immunotherapy"],"prefix":"10.1007","volume":"68","author":[{"given":"Jafar","family":"Mahmoudian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Ghaffari-Tabrizi-Wizsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Nasser","family":"Ostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Hassan","family":"Zarnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"issue":"5","key":"2350_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg Robert A (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"17","key":"2350_CR2","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","volume":"15","author":"MA Cheever","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res Off J Am Assoc Cancer Res 15(17):5323\u20135337. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0737","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2350_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.ai.2016.01.001","volume":"130","author":"JP Ward","year":"2016","unstructured":"Ward JP, Gubin MM, Schreiber RD (2016) The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer. Adv Immunol 130:25\u201374. https:\/\/doi.org\/10.1016\/bs.ai.2016.01.001","journal-title":"Adv Immunol"},{"issue":"9","key":"2350_CR4","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1172\/JCI80008","volume":"125","author":"MM Gubin","year":"2015","unstructured":"Gubin MM, Artyomov MN, Mardis ER, Schreiber RD (2015) Tumor neoantigens: building a framework for personalized cancer immunotherapy. J Clin Investig 125(9):3413\u20133421. https:\/\/doi.org\/10.1172\/JCI80008","journal-title":"J Clin Investig"},{"issue":"2","key":"2350_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrc3670","volume":"14","author":"PG Coulie","year":"2014","unstructured":"Coulie PG, Van den Eynde BJ, van der Bruggen P, Boon T (2014) Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 14(2):135\u2013146. https:\/\/doi.org\/10.1038\/nrc3670","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2350_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5(8):615\u2013625. https:\/\/doi.org\/10.1038\/nrc1669","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2350_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrc.2016.154","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Johnson BA 3rd, Lutz ER, Laheru DA, Jaffee EM (2017) Targeting neoantigens to augment antitumour immunity. Nat Rev Cancer 17(4):209\u2013222. https:\/\/doi.org\/10.1038\/nrc.2016.154","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"2350_CR8","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690","journal-title":"N Engl J Med"},{"issue":"7","key":"2350_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","volume":"45","author":"A Salmaninejad","year":"2016","unstructured":"Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N (2016) Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Investig 45(7):619\u2013640. https:\/\/doi.org\/10.1080\/08820139.2016.1197241","journal-title":"Immunol Investig"},{"key":"2350_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7827-2-15","volume":"2","author":"R Soundararajan","year":"2004","unstructured":"Soundararajan R, Rao AJ (2004) Trophoblast \u2018pseudo-tumorigenesis\u2019: significance and contributory factors. Reprod Biol Endocrinol RBE 2:15. https:\/\/doi.org\/10.1186\/1477-7827-2-15","journal-title":"Reprod Biol Endocrinol RBE"},{"issue":"3","key":"2350_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000092537","volume":"52","author":"JR Wilczynski","year":"2006","unstructured":"Wilczynski JR (2006) Cancer and pregnancy share similar mechanisms of immunological escape. Chemotherapy 52(3):107\u2013110. https:\/\/doi.org\/10.1159\/000092537","journal-title":"Chemotherapy"},{"issue":"2","key":"2350_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0303-7207(01)00550-0","volume":"182","author":"S Rama","year":"2001","unstructured":"Rama S, Suresh Y, Rao AJ (2001) Regulation of telomerase during human placental differentiation: a role for TGFbeta1. Mol Cell Endocrinol 182(2):233\u2013248","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2350_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ydbio.2004.12.035","volume":"279","author":"JF Weier","year":"2005","unstructured":"Weier JF, Weier HU, Jung CJ, Gormley M, Zhou Y, Chu LW, Genbacev O, Wright AA, Fisher SJ (2005) Human cytotrophoblasts acquire aneuploidies as they differentiate to an invasive phenotype. Dev Biol 279(2):420\u2013432. https:\/\/doi.org\/10.1016\/j.ydbio.2004.12.035","journal-title":"Dev Biol"},{"issue":"3","key":"2350_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2353\/ajpath.2007.060641","volume":"170","author":"RW Chiu","year":"2007","unstructured":"Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF, Tong JH, Yuen RK, Shum AS, Chan JK, Chan LY, Yuen JW, Tong YK, Weier JF, Ferlatte C, Leung TN, Lau TK, Lo KW, Lo YM (2007) Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170(3):941\u2013950. https:\/\/doi.org\/10.2353\/ajpath.2007.060641","journal-title":"Am J Pathol"},{"issue":"4","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1534735408326174","volume":"7","author":"RW Moss","year":"2008","unstructured":"Moss RW (2008) The life and times of John Beard, DSc (1858\u20131924). Integr Cancer Ther 7(4):229\u2013251. https:\/\/doi.org\/10.1177\/1534735408326174","journal-title":"Integr Cancer Ther"},{"key":"2350_CR16","first-page":"19","volume":"7","author":"LJ Old","year":"2007","unstructured":"Old LJ (2007) Cancer is a somatic cell pregnancy. Cancer Immun 7:19","journal-title":"Cancer Immun"},{"issue":"3","key":"2350_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/geno.2000.6302","volume":"68","author":"M Cocchia","year":"2000","unstructured":"Cocchia M, Huber R, Pantano S, Chen EY, Ma P, Forabosco A, Ko MS, Schlessinger D (2000) PLAC1, an Xq26 gene with placenta-specific expression. Genomics 68(3):305\u2013312. https:\/\/doi.org\/10.1006\/geno.2000.6302","journal-title":"Genomics"},{"issue":"1","key":"2350_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/dbio.2002.0870","volume":"253","author":"H Suemizu","year":"2003","unstructured":"Suemizu H, Aiba K, Yoshikawa T, Sharov AA, Shimozawa N, Tamaoki N, Ko MS (2003) Expression profiling of placentomegaly associated with nuclear transplantation of mouse ES cells. Dev Biol 253(1):36\u201353","journal-title":"Dev Biol"},{"issue":"1","key":"2350_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/dvdy.20024","volume":"230","author":"U Singh","year":"2004","unstructured":"Singh U, Fohn LE, Wakayama T, Ohgane J, Steinhoff C, Lipkowitz B, Schulz R, Orth A, Ropers HH, Behringer RR, Tanaka S, Shiota K, Yanagimachi R, Nuber UA, Fundele R (2004) Different molecular mechanisms underlie placental overgrowth phenotypes caused by interspecies hybridization, cloning, and Esx1 mutation. Dev Dyn Off Publ Am Assoc Anat 230(1):149\u2013164. https:\/\/doi.org\/10.1002\/dvdy.20024","journal-title":"Dev Dyn Off Publ Am Assoc Anat"},{"issue":"8","key":"2350_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/mrd.22062","volume":"79","author":"SM Jackman","year":"2012","unstructured":"Jackman SM, Kong X, Fant ME (2012) Plac1 (placenta-specific 1) is essential for normal placental and embryonic development. Mol Reprod Dev 79(8):564\u2013572. https:\/\/doi.org\/10.1002\/mrd.22062","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"2350_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1095\/biolreprod.115.133454","volume":"94","author":"M Muto","year":"2016","unstructured":"Muto M, Fujihara Y, Tobita T, Kiyozumi D, Ikawa M (2016) Lentiviral vector-mediated complementation restored fetal viability but not placental hyperplasia in Plac1-deficient mice. Biol Reprod 94(1):6. https:\/\/doi.org\/10.1095\/biolreprod.115.133454","journal-title":"Biol Reprod"},{"issue":"19","key":"2350_CR22","doi-asserted-by":"publisher","first-page":"9528","DOI":"10.1158\/0008-5472.CAN-07-1350","volume":"67","author":"M Koslowski","year":"2007","unstructured":"Koslowski M, Sahin U, Mitnacht-Kraus R, Seitz G, Huber C, Tureci O (2007) A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Can Res 67(19):9528\u20139534. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1350","journal-title":"Can Res"},{"key":"2350_CR23","first-page":"18","volume":"7","author":"WA Silva Jr","year":"2007","unstructured":"Silva WA Jr, Gnjatic S, Ritter E, Chua R, Cohen T, Hsu M, Jungbluth AA, Altorki NK, Chen YT, Old LJ, Simpson AJ, Caballero OL (2007) PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun 7:18","journal-title":"Cancer Immun"},{"key":"2350_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1743-422X-11-107","volume":"11","author":"X Wang","year":"2014","unstructured":"Wang X, Baddoo MC, Yin Q (2014) The placental specific gene, PLAC1, is induced by the Epstein\u2013Barr virus and is expressed in human tumor cells. Virol J 11:107. https:\/\/doi.org\/10.1186\/1743-422X-11-107","journal-title":"Virol J"},{"issue":"2","key":"2350_CR25","doi-asserted-by":"publisher","first-page":"e0192106","DOI":"10.1371\/journal.pone.0192106","volume":"13","author":"H Yuan","year":"2018","unstructured":"Yuan H, Chen V, Boisvert M, Isaacs C, Glazer RI (2018) PLAC1 as a serum biomarker for breast cancer. PLoS One 13(2):e0192106. https:\/\/doi.org\/10.1371\/journal.pone.0192106","journal-title":"PLoS One"},{"key":"2350_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12311","author":"Y Li","year":"2018","unstructured":"Li Y, Chu J, Li J, Feng W, Yang F, Wang Y, Zhang Y, Sun C, Yang M, Vasilatos SN, Huang Y, Fu Z, Yin Y (2018) Cancer\/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin\/NICD\/PTEN signaling pathway. Mol Oncol. https:\/\/doi.org\/10.1002\/1878-0261.12311","journal-title":"Mol Oncol"},{"issue":"9","key":"2350_CR27","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/ijc.23341","volume":"122","author":"XY Dong","year":"2008","unstructured":"Dong XY, Peng JR, Ye YJ, Chen HS, Zhang LJ, Pang XW, Li Y, Zhang Y, Wang S, Fant ME, Yin YH, Chen WF (2008) Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients. Int J Cancer 122(9):2038\u20132043. https:\/\/doi.org\/10.1002\/ijc.23341","journal-title":"Int J Cancer"},{"issue":"1","key":"2350_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/or.2017.6086","volume":"39","author":"L Yang","year":"2018","unstructured":"Yang L, Zha TQ, He X, Chen L, Zhu Q, Wu WB, Nie FQ, Wang Q, Zang CS, Zhang ML, He J, Li W, Jiang W, Lu KH (2018) Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer. Oncol Rep 39(1):53\u201360. https:\/\/doi.org\/10.3892\/or.2017.6086","journal-title":"Oncol Rep"},{"issue":"1","key":"2350_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3892\/or.2016.5272","volume":"37","author":"Y Wu","year":"2017","unstructured":"Wu Y, Lin X, Di X, Chen Y, Zhao H, Wang X (2017) Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells. Oncol Rep 37(1):465\u2013473. https:\/\/doi.org\/10.3892\/or.2016.5272","journal-title":"Oncol Rep"},{"issue":"4","key":"2350_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1053\/j.gastro.2008.01.029","volume":"134","author":"FF Liu","year":"2008","unstructured":"Liu FF, Dong XY, Pang XW, Xing Q, Wang HC, Zhang HG, Li Y, Yin YH, Fant M, Ye YJ, Shen DH, Zhang Y, Wang S, Chen WF (2008) The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients. Gastroenterology 134(4):998\u20131006. https:\/\/doi.org\/10.1053\/j.gastro.2008.01.029","journal-title":"Gastroenterology"},{"key":"2350_CR31","first-page":"16","volume":"12","author":"HM Shantha Kumara","year":"2012","unstructured":"Shantha Kumara HM, Grieco MJ, Caballero OL, Su T, Ahmed A, Ritter E, Gnjatic S, Cekic V, Old LJ, Simpson AJ, Cordon-Cardo C, Whelan RL (2012) MAGE-A3 is highly expressed in a subset of colorectal cancer patients. Cancer Immun 12:16","journal-title":"Cancer Immun"},{"issue":"3","key":"2350_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00535-013-0811-4","volume":"49","author":"F Liu","year":"2013","unstructured":"Liu F, Zhang H, Shen D, Wang S, Ye Y, Chen H, Pang X, Song Q, He P (2013) Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1\/CP1. J Gastroenterol 49(3):419\u2013426. https:\/\/doi.org\/10.1007\/s00535-013-0811-4","journal-title":"J Gastroenterol"},{"issue":"2","key":"2350_CR33","first-page":"124","volume":"38","author":"J Chen","year":"2006","unstructured":"Chen J, Pang XW, Liu FF, Dong XY, Wang HC, Wang S, Zhang Y, Chen WF (2006) PLAC1\/CP1 gene expression and autologous humoral immunity in gastric cancer patients. Beijing da xue xue bao Yi xue ban (Journal of Peking University Health Sciences) 38(2):124\u2013127","journal-title":"Beijing da xue xue bao Yi xue ban (Journal of Peking University Health Sciences)"},{"issue":"11","key":"2350_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/jclinpath-2015-202978","volume":"68","author":"F Liu","year":"2015","unstructured":"Liu F, Shen D, Kang X, Zhang C, Song Q (2015) New tumour antigen PLAC1\/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma. J Clin Pathol 68(11):913\u2013916. https:\/\/doi.org\/10.1136\/jclinpath-2015-202978","journal-title":"J Clin Pathol"},{"key":"2350_CR35","first-page":"6","volume":"9","author":"NE Tchabo","year":"2009","unstructured":"Tchabo NE, Mhawech-Fauceglia P, Caballero OL, Villella J, Beck AF, Miliotto AJ, Liao J, Andrews C, Lele S, Old LJ, Odunsi K (2009) Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer Immun 9:6","journal-title":"Cancer Immun"},{"key":"2350_CR36","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.3931","author":"EJ Devor","year":"2017","unstructured":"Devor EJ, Gonzalez-Bosquet J, Warrier A, Reyes HD, Ibik NV, Schickling BM, Newtson A, Goodheart MJ, Leslie KK (2017) p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2017.3931","journal-title":"Int J Oncol"},{"key":"2350_CR37","doi-asserted-by":"publisher","first-page":"807849","DOI":"10.1155\/2013\/807849","volume":"2013","author":"EJ Devor","year":"2013","unstructured":"Devor EJ, Leslie KK (2013) The oncoplacental gene placenta-specific protein 1 is highly expressed in endometrial tumors and cell lines. Obstet Gynecol Int 2013:807849. https:\/\/doi.org\/10.1155\/2013\/807849","journal-title":"Obstet Gynecol Int"},{"key":"2350_CR38","doi-asserted-by":"publisher","first-page":"678984","DOI":"10.1155\/2014\/678984","volume":"2014","author":"EJ Devor","year":"2014","unstructured":"Devor EJ, Reyes HD, Santillan DA, Santillan MK, Onukwugha C, Goodheart MJ, Leslie KK (2014) Placenta-specific protein 1: a potential key to many oncofetal-placental OB\/GYN research questions. Obstet Gynecol Int 2014:678984. https:\/\/doi.org\/10.1155\/2014\/678984","journal-title":"Obstet Gynecol Int"},{"key":"2350_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/igc.0000000000000957","author":"EJ Devor","year":"2017","unstructured":"Devor EJ, Reyes HD, Gonzalez-Bosquet J, Warrier A, Kenzie SA, Ibik NV, Miller MD, Schickling BM, Goodheart MJ, Thiel KW, Leslie KK (2017) Placenta-specific protein 1 expression in human papillomavirus 16\/18-positive cervical cancers is associated with tumor histology. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. https:\/\/doi.org\/10.1097\/igc.0000000000000957","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"6","key":"2350_CR40","doi-asserted-by":"publisher","first-page":"101042831769913","DOI":"10.1177\/1010428317699131","volume":"39","author":"Y Yin","year":"2017","unstructured":"Yin Y, Zhu X, Huang S, Zheng J, Zhang M, Kong W, Chen Q, Zhang Y, Chen X, Lin K, Ouyang X (2017) Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Tumour Biol J Int Soc Oncodev Biol Med 39(6):1010428317699131. https:\/\/doi.org\/10.1177\/1010428317699131","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"issue":"12","key":"2350_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00262-014-1594-z","volume":"63","author":"R Ghods","year":"2014","unstructured":"Ghods R, Ghahremani MH, Madjd Z, Asgari M, Abolhasani M, Tavasoli S, Mahmoudi AR, Darzi M, Pasalar P, Jeddi-Tehrani M, Zarnani AH (2014) High placenta-specific 1\/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma. Cancer Immunol Immunother CII 63(12):1319\u20131327. https:\/\/doi.org\/10.1007\/s00262-014-1594-z","journal-title":"Cancer Immunol Immunother CII"},{"issue":"11","key":"2350_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.placenta.2011.08.011","volume":"32","author":"Y Chen","year":"2011","unstructured":"Chen Y, Moradin A, Schlessinger D, Nagaraja R (2011) RXRalpha and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1. Placenta 32(11):877\u2013884. https:\/\/doi.org\/10.1016\/j.placenta.2011.08.011","journal-title":"Placenta"},{"key":"2350_CR43","doi-asserted-by":"publisher","first-page":"537356","DOI":"10.1155\/2014\/537356","volume":"2014","author":"EJ Devor","year":"2014","unstructured":"Devor EJ (2014) Placenta-specific protein 1 is conserved throughout the placentalia under purifying selection. Sci World J 2014:537356. https:\/\/doi.org\/10.1155\/2014\/537356","journal-title":"Sci World J"},{"issue":"3","key":"2350_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.15761\/ICST.1000192","volume":"3","author":"EJ Devor","year":"2016","unstructured":"Devor EJ (2016) Placenta-specific protein 1 (PLAC1) is a unique onco-fetal-placental protein and an underappreciated therapeutic target in cancer. Integr Cancer Sci Ther 3(3):479\u2013483","journal-title":"Integr Cancer Sci Ther"},{"issue":"1","key":"2350_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0092-8674(82)90384-1","volume":"28","author":"M Carlson","year":"1982","unstructured":"Carlson M, Botstein D (1982) Two differentially regulated mRNAs with different 5\u2032 ends encode secreted with intracellular forms of yeast invertase. Cell 28(1):145\u2013154","journal-title":"Cell"},{"key":"2350_CR46","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1038\/oncsis.2013.31","volume":"2","author":"Y Chen","year":"2013","unstructured":"Chen Y, Schlessinger D, Nagaraja R (2013) T antigen transformation reveals Tp53\/RB-dependent route to PLAC1 transcription activation in primary fibroblasts. Oncogenesis 2:e67. https:\/\/doi.org\/10.1038\/oncsis.2013.31","journal-title":"Oncogenesis"},{"issue":"14","key":"2350_CR47","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1073\/pnas.93.14.7149","volume":"93","author":"C De Smet","year":"1996","unstructured":"De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93(14):7149\u20137153","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2350_CR48","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","volume":"19","author":"C De Smet","year":"1999","unstructured":"De Smet C, Lurquin C, Lethe B, Martelange V, Boon T (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19(11):7327\u20137335","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2350_CR49","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.bjc.6601600","volume":"90","author":"T Honda","year":"2004","unstructured":"Honda T, Tamura G, Waki T, Kawata S, Terashima M, Nishizuka S, Motoyama T (2004) Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 90(4):838\u2013843. https:\/\/doi.org\/10.1038\/sj.bjc.6601600","journal-title":"Br J Cancer"},{"issue":"17","key":"2350_CR50","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1158\/0008-5472.CAN-04-1187","volume":"64","author":"M Koslowski","year":"2004","unstructured":"Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Muntefering H, Huber C, Sahin U, Tureci O (2004) Frequent nonrandom activation of germ-line genes in human cancer. Can Res 64(17):5988\u20135993. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1187","journal-title":"Can Res"},{"issue":"42","key":"2350_CR51","doi-asserted-by":"publisher","first-page":"28607","DOI":"10.1074\/jbc.M109.031120","volume":"284","author":"M Koslowski","year":"2009","unstructured":"Koslowski M, Tureci O, Biesterfeld S, Seitz G, Huber C, Sahin U (2009) Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT\/enhancer-binding protein beta (C\/EBPbeta) isoform 2. J Biol Chem 284(42):28607\u201328615. https:\/\/doi.org\/10.1074\/jbc.M109.031120","journal-title":"J Biol Chem"},{"key":"2350_CR52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/1471-2407-13-570","volume":"13","author":"M Wagner","year":"2013","unstructured":"Wagner M, Koslowski M, Paret C, Schmidt M, Tureci O, Sahin U (2013) NCOA3 is a selective co-activator of estrogen receptor alpha-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC Cancer 13:570. https:\/\/doi.org\/10.1186\/1471-2407-13-570","journal-title":"BMC Cancer"},{"issue":"8","key":"2350_CR53","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/carcin\/bgt107","volume":"34","author":"N Nagpal","year":"2013","unstructured":"Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R (2013) MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 34(8):1889\u20131899. https:\/\/doi.org\/10.1093\/carcin\/bgt107","journal-title":"Carcinogenesis"},{"issue":"14","key":"2350_CR54","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1158\/0008-5472.CAN-13-0322","volume":"73","author":"H Yuan","year":"2013","unstructured":"Yuan H, Lu J, Xiao J, Upadhyay G, Umans R, Kallakury B, Yin Y, Fant ME, Kopelovich L, Glazer RI (2013) PPARdelta induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation. Can Res 73(14):4349\u20134361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0322","journal-title":"Can Res"},{"issue":"5","key":"2350_CR55","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1161\/01.RES.0000260805.99076.22","volume":"100","author":"L Brunelli","year":"2007","unstructured":"Brunelli L, Cieslik KA, Alcorn JL, Vatta M, Baldini A (2007) Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT\/enhancer binding protein-beta. Circ Res 100(5):e59\u2013e71. https:\/\/doi.org\/10.1161\/01.RES.0000260805.99076.22","journal-title":"Circ Res"},{"issue":"2","key":"2350_CR56","first-page":"257","volume":"24","author":"XL Li","year":"2004","unstructured":"Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama Y, Tani M, Takizawa T, Koike M, Yuasa Y (2004) Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol 24(2):257\u2013263","journal-title":"Int J Oncol"},{"issue":"4","key":"2350_CR57","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/sj.bjc.6604193","volume":"98","author":"T Otsubo","year":"2008","unstructured":"Otsubo T, Akiyama Y, Yanagihara K, Yuasa Y (2008) SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 98(4):824\u2013831. https:\/\/doi.org\/10.1038\/sj.bjc.6604193","journal-title":"Br J Cancer"},{"issue":"1","key":"2350_CR58","doi-asserted-by":"publisher","first-page":"e16617","DOI":"10.1371\/journal.pone.0016617","volume":"6","author":"T Otsubo","year":"2011","unstructured":"Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y (2011) MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 6(1):e16617. https:\/\/doi.org\/10.1371\/journal.pone.0016617","journal-title":"PLoS One"},{"issue":"4","key":"2350_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mrd.10200","volume":"63","author":"M Fant","year":"2002","unstructured":"Fant M, Weisoly DL, Cocchia M, Huber R, Khan S, Lunt T, Schlessinger D (2002) PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev 63(4):430\u2013436. https:\/\/doi.org\/10.1002\/mrd.10200","journal-title":"Mol Reprod Dev"},{"issue":"3","key":"2350_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/mrd.20272","volume":"71","author":"E Massabbal","year":"2005","unstructured":"Massabbal E, Parveen S, Weisoly DL, Nelson DM, Smith SD, Fant M (2005) PLAC1 expression increases during trophoblast differentiation: evidence for regulatory interactions with the fibroblast growth factor-7 (FGF-7) axis. Mol Reprod Dev 71(3):299\u2013304. https:\/\/doi.org\/10.1002\/mrd.20272","journal-title":"Mol Reprod Dev"},{"issue":"5","key":"2350_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1677\/JME-08-0103","volume":"41","author":"S Safe","year":"2008","unstructured":"Safe S, Kim K (2008) Non-classical genomic estrogen receptor (ER)\/specificity protein and ER\/activating protein-1 signaling pathways. J Mol Endocrinol 41(5):263\u2013275. https:\/\/doi.org\/10.1677\/JME-08-0103","journal-title":"J Mol Endocrinol"},{"issue":"45","key":"2350_CR62","doi-asserted-by":"publisher","first-page":"29864","DOI":"10.1074\/jbc.273.45.29864","volume":"273","author":"RC Muise-Helmericks","year":"1998","unstructured":"Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N (1998) Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase\/Akt-dependent pathway. J Biol Chem 273(45):29864\u201329872","journal-title":"J Biol Chem"},{"issue":"42","key":"2350_CR63","doi-asserted-by":"publisher","first-page":"32649","DOI":"10.1074\/jbc.M000643200","volume":"275","author":"M D\u2019Amico","year":"2000","unstructured":"D\u2019Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze\u2019ev A, Troussard AA, Dedhar S, Pestell RG (2000) The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275(42):32649\u201332657. https:\/\/doi.org\/10.1074\/jbc.M000643200","journal-title":"J Biol Chem"},{"issue":"3","key":"2350_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.repbio.2016.07.001","volume":"16","author":"WL Chang","year":"2016","unstructured":"Chang WL, Wang H, Cui L, Peng NN, Fan X, Xue LQ, Yang Q (2016) PLAC1 is involved in human trophoblast syncytialization. Reprod Biol 16(3):218\u2013224. https:\/\/doi.org\/10.1016\/j.repbio.2016.07.001","journal-title":"Reprod Biol"},{"issue":"7","key":"2350_CR65","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/mrd.20673","volume":"74","author":"M Fant","year":"2007","unstructured":"Fant M, Barerra-Saldana H, Dubinsky W, Poindexter B, Bick R (2007) The PLAC1 protein localizes to membranous compartments in the apical region of the syncytiotrophoblast. Mol Reprod Dev 74(7):922\u2013929. https:\/\/doi.org\/10.1002\/mrd.20673","journal-title":"Mol Reprod Dev"},{"issue":"3","key":"2350_CR66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/bab.1177","volume":"61","author":"R Ghods","year":"2014","unstructured":"Ghods R, Ghahremani MH, Darzi M, Mahmoudi AR, Yeganeh O, Bayat AA, Pasalar P, Jeddi-Tehrani M, Zarnani AH (2014) Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta-specific 1. Biotechnol Appl Biochem 61(3):363\u2013369. https:\/\/doi.org\/10.1002\/bab.1177","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"2350_CR67","doi-asserted-by":"publisher","first-page":"13373","DOI":"10.1038\/s41598-017-13682-9","volume":"7","author":"MR Nejadmoghaddam","year":"2017","unstructured":"Nejadmoghaddam MR, Zarnani AH, Ghahremanzadeh R, Ghods R, Mahmoudian J, Yousefi M, Nazari M, Ghahremani MH, Abolhasani M, Anissian A, Mahmoudi M, Dinarvand R (2017) Placenta-specific1 (PLAC1) is a potential target for antibody\u2013drug conjugate-based prostate cancer immunotherapy. Sci Rep 7(1):13373. https:\/\/doi.org\/10.1038\/s41598-017-13682-9","journal-title":"Sci Rep"},{"issue":"3","key":"2350_CR68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(92)80853-9","volume":"300","author":"P Bork","year":"1992","unstructured":"Bork P, Sander C (1992) A large domain common to sperm receptors (Zp2 and Zp3) and TGF-\u03b2 type III receptor. FEBS Lett 300(3):237\u2013240. https:\/\/doi.org\/10.1016\/0014-5793(92)80853-9","journal-title":"FEBS Lett"},{"key":"2350_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.biochem.74.082803.133039","volume":"74","author":"L Jovine","year":"2005","unstructured":"Jovine L, Darie CC, Litscher ES, Wassarman PM (2005) Zona pellucida domain proteins. Annu Rev Biochem 74:83\u2013114. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133039","journal-title":"Annu Rev Biochem"},{"issue":"16","key":"2350_CR70","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1073\/pnas.0401600101","volume":"101","author":"L Jovine","year":"2004","unstructured":"Jovine L, Qi H, Williams Z, Litscher ES, Wassarman PM (2004) A duplicated motif controls assembly of zona pellucida domain proteins. Proc Natl Acad Sci USA 101(16):5922\u20135927. https:\/\/doi.org\/10.1073\/pnas.0401600101","journal-title":"Proc Natl Acad Sci USA"},{"key":"2350_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2091-7-11","volume":"7","author":"L Jovine","year":"2006","unstructured":"Jovine L, Janssen WG, Litscher ES, Wassarman PM (2006) The PLAC1-homology region of the ZP domain is sufficient for protein polymerisation. BMC Biochem 7:11. https:\/\/doi.org\/10.1186\/1471-2091-7-11","journal-title":"BMC Biochem"},{"key":"2350_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pep.2017.03.011","volume":"133","author":"M Nazari","year":"2017","unstructured":"Nazari M, Zarnani AH, Ghods R, Emamzadeh R, Najafzadeh S, Minai-Tehrani A, Mahmoudian J, Yousefi M, Vafaei S, Massahi S, Nejadmoghaddam MR (2017) Optimized protocol for soluble prokaryotic expression, purification and structural analysis of human placenta specific-1 (PLAC1). Protein Expr Purif 133:139\u2013151. https:\/\/doi.org\/10.1016\/j.pep.2017.03.011","journal-title":"Protein Expr Purif"},{"issue":"3\u20134","key":"2350_CR73","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0097-8485(99)00012-1","volume":"23","author":"J Heringa","year":"1999","unstructured":"Heringa J (1999) Two strategies for sequence comparison: profile-preprocessed and secondary structure-induced multiple alignment. Comput Chem 23(3\u20134):341\u2013364. https:\/\/doi.org\/10.1016\/s0097-8485(99)00012-1","journal-title":"Comput Chem"},{"issue":"Web Server issu","key":"2350_CR74","doi-asserted-by":"publisher","first-page":"W289","DOI":"10.1093\/nar\/gki390","volume":"33","author":"VA Simossis","year":"2005","unstructured":"Simossis VA, Heringa J (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res 33(Web Server issue):W289\u2013W294. https:\/\/doi.org\/10.1093\/nar\/gki390","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2350_CR75","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1159\/000484154","volume":"43","author":"Y Gu","year":"2017","unstructured":"Gu Y, Wan J, Yao L, Peng NN, Chang WL (2017) Plac1 expression pattern at the mouse fetomaternal interface and involvement in trophoblast differentiation. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 43(5):2001\u20132009. https:\/\/doi.org\/10.1159\/000484154","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"2350_CR76","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700922rr","author":"LY Shi","year":"2018","unstructured":"Shi LY, Ma Y, Zhu GY, Liu JW, Zhou CX, Chen LJ, Wang Y, Li RC, Yang ZX, Zhang D (2018) Placenta-specific 1 regulates oocyte meiosis and fertilization through furin. FASEB J Off Publ Fed Am Soc Exp Biol. https:\/\/doi.org\/10.1096\/fj.201700922rr","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"9","key":"2350_CR77","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/bdra.23171","volume":"97","author":"X Kong","year":"2013","unstructured":"Kong X, Jackman SM, Fant ME (2013) Plac1 (placenta-specific 1) is widely expressed during fetal development and is associated with a lethal form of hydrocephalus. Birth Defects Res A 97(9):571\u2013577. https:\/\/doi.org\/10.1002\/bdra.23171","journal-title":"Birth Defects Res A"},{"issue":"4","key":"2350_CR78","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/REP-14-0052","volume":"148","author":"WL Chang","year":"2014","unstructured":"Chang WL, Yang Q, Zhang H, Lin HY, Zhou Z, Lu X, Zhu C, Xue LQ, Wang H (2014) Role of placenta-specific protein 1 in trophoblast invasion and migration. Reproduction 148(4):343\u2013352. https:\/\/doi.org\/10.1530\/REP-14-0052","journal-title":"Reproduction"},{"issue":"6","key":"2350_CR79","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00726-011-0966-3","volume":"42","author":"W Liu","year":"2011","unstructured":"Liu W, Zhai M, Wu Z, Qi Y, Wu Y, Dai C, Sun M, Li L, Gao Y (2011) Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer\u2013testis antigen PLAC1 in breast cancer. Amino Acids 42(6):2257\u20132265. https:\/\/doi.org\/10.1007\/s00726-011-0966-3","journal-title":"Amino Acids"},{"issue":"5","key":"2350_CR80","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.3892\/mmr.2017.7372","volume":"16","author":"L Guo","year":"2017","unstructured":"Guo L, Xu D, Lu Y, Peng J, Jiang L (2017) Detection of circulating tumor cells by reverse transcriptionquantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma. Mol Med Rep 16(5):5894\u20135900. https:\/\/doi.org\/10.3892\/mmr.2017.7372","journal-title":"Mol Med Rep"},{"issue":"2","key":"2350_CR81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molonc.2011.02.001","volume":"5","author":"E Fratta","year":"2011","unstructured":"Fratta E, Coral S, Covre A, Parisi G, Colizzi F, Danielli R, Nicolay HJ, Sigalotti L, Maio M (2011) The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol 5(2):164\u2013182. https:\/\/doi.org\/10.1016\/j.molonc.2011.02.001","journal-title":"Mol Oncol"},{"issue":"51","key":"2350_CR82","doi-asserted-by":"publisher","first-page":"20422","DOI":"10.1073\/pnas.0810777105","volume":"105","author":"O Hofmann","year":"2008","unstructured":"Hofmann O, Caballero OL, Stevenson BJ, Chen YT, Cohen T, Chua R, Maher CA, Panji S, Schaefer U, Kruger A, Lehvaslaiho M, Carninci P, Hayashizaki Y, Jongeneel CV, Simpson AJ, Old LJ, Hide W (2008) Genome-wide analysis of cancer\/testis gene expression. Proc Natl Acad Sci USA 105(51):20422\u201320427. https:\/\/doi.org\/10.1073\/pnas.0810777105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2350_CR83","first-page":"15","volume":"7","author":"AA Jungbluth","year":"2007","unstructured":"Jungbluth AA, Silva WA Jr, Iversen K, Frosina D, Zaidi B, Coplan K, Eastlake-Wade SK, Castelli SB, Spagnoli GC, Old LJ, Vogel M (2007) Expression of cancer\u2013testis (CT) antigens in placenta. Cancer Immun 7:15","journal-title":"Cancer Immun"},{"issue":"4","key":"2350_CR84","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4161\/cbt.1.4.11","volume":"1","author":"ZM Cilensek","year":"2002","unstructured":"Cilensek ZM, Yehiely F, Kular RK, Deiss LP (2002) A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas\/CD95\/APO-1, Interferon-gamma, taxol and gamma-irradiation. Cancer Biol Ther 1(4):380\u2013387","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"2350_CR85","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1074\/jbc.M206104200","volume":"278","author":"T Nagao","year":"2003","unstructured":"Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, Itoh K, Fujita J (2003) MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 278(12):10668\u201310674. https:\/\/doi.org\/10.1074\/jbc.M206104200","journal-title":"J Biol Chem"},{"issue":"14","key":"2350_CR86","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/nar\/gkh735","volume":"32","author":"S Laduron","year":"2004","unstructured":"Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C, Hayward SD, Fuks F, Boon T, De Plaen E (2004) MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res 32(14):4340\u20134350. https:\/\/doi.org\/10.1093\/nar\/gkh735","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2350_CR87","first-page":"2778","volume":"9","author":"Z Duan","year":"2003","unstructured":"Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT, Seiden MV (2003) Overexpression of MAGE\/GAGE genes in paclitaxel\/doxorubicin-resistant human cancer cell lines. Clin Cancer Res Off J Am Assoc Cancer Res 9(7):2778\u20132785","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"2350_CR88","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1016-8478(23)15082-5","volume":"14","author":"JH Park","year":"2002","unstructured":"Park JH, Kong GH, Lee SW (2002) hMAGE-A1 overexpression reduces TNF-alpha cytotoxicity in ME-180 cells. Mol Cells 14(1):122\u2013129","journal-title":"Mol Cells"},{"issue":"5","key":"2350_CR89","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1101\/gr.103200.109","volume":"20","author":"F Yang","year":"2010","unstructured":"Yang F, Babak T, Shendure J, Disteche CM (2010) Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Res 20(5):614\u2013622. https:\/\/doi.org\/10.1101\/gr.103200.109","journal-title":"Genome Res"},{"issue":"1","key":"2350_CR90","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/dbio.2000.9705","volume":"222","author":"M Hemberger","year":"2000","unstructured":"Hemberger M, Himmelbauer H, Ruschmann J, Zeitz C, Fundele R (2000) cDNA subtraction cloning reveals novel genes whose temporal and spatial expression indicates association with trophoblast invasion. Dev Biol 222(1):158\u2013169. https:\/\/doi.org\/10.1006\/dbio.2000.9705","journal-title":"Dev Biol"},{"issue":"1","key":"2350_CR91","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1038\/s41598-018-24022-w","volume":"8","author":"H Yuan","year":"2018","unstructured":"Yuan H, Wang X, Shi C, Jin L, Hu J, Zhang A, Li J, Vijayendra N, Doodala V, Weiss S, Tang Y, Weiner LM, Glazer RI (2018) Plac1 is a key regulator of the inflammatory response and immune tolerance in mammary tumorigenesis. Sci Rep 8(1):5717. https:\/\/doi.org\/10.1038\/s41598-018-24022-w","journal-title":"Sci Rep"},{"key":"2350_CR92","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1479-5876-12-204","volume":"12","author":"S Sarker","year":"2014","unstructured":"Sarker S, Scholz-Romero K, Perez A, Illanes SE, Mitchell MD, Rice GE, Salomon C (2014) Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. J Transl Med 12:204. https:\/\/doi.org\/10.1186\/1479-5876-12-204","journal-title":"J Transl Med"},{"key":"2350_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/SCCAA.S84991","volume":"8","author":"IM Saadeldin","year":"2015","unstructured":"Saadeldin IM, Oh HJ, Lee BC (2015) Embryonic-maternal cross-talk via exosomes: potential implications. Stem Cells Cloning Adv Appl 8:103\u2013107. https:\/\/doi.org\/10.2147\/SCCAA.S84991","journal-title":"Stem Cells Cloning Adv Appl"},{"issue":"3","key":"2350_CR94","doi-asserted-by":"publisher","first-page":"a023028","DOI":"10.1101\/cshperspect.a023028","volume":"5","author":"M Tong","year":"2015","unstructured":"Tong M, Chamley LW (2015) Placental extracellular vesicles and feto-maternal communication. Cold Spring Harbor Perspect Med 5(3):a023028. https:\/\/doi.org\/10.1101\/cshperspect.a023028","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2350_CR95","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.placenta.2017.07.242","volume":"57","author":"A Lai","year":"2017","unstructured":"Lai A, Rice G, Salomon C (2017) Specific isolation of placenta-derived exosomes from maternal circulation. Placenta 57:300. https:\/\/doi.org\/10.1016\/j.placenta.2017.07.242","journal-title":"Placenta"},{"issue":"1","key":"2350_CR96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jri.2003.10.001","volume":"61","author":"R Austgulen","year":"2004","unstructured":"Austgulen R, Isaksen CV, Chedwick L, Romundstad P, Vatten L, Craven C (2004) Pre-eclampsia: associated with increased syncytial apoptosis when the infant is small-for-gestational-age. J Reprod Immunol 61(1):39\u201350. https:\/\/doi.org\/10.1016\/j.jri.2003.10.001","journal-title":"J Reprod Immunol"},{"issue":"1","key":"2350_CR97","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1373\/clinchem.2003.023259","volume":"50","author":"A Sekizawa","year":"2004","unstructured":"Sekizawa A, Farina A, Sugito Y, Matsuoka R, Iwasaki M, Saito H, Okai T (2004) Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin Chem 50(1):221\u2013224. https:\/\/doi.org\/10.1373\/clinchem.2003.023259","journal-title":"Clin Chem"},{"issue":"1","key":"2350_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000081365","volume":"20","author":"M Concu","year":"2005","unstructured":"Concu M, Banzola I, Farina A, Sekizawa A, Rizzo N, Marini M, Caramelli E, Carinci P (2005) Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. Fetal Diagn Ther 20(1):27\u201330. https:\/\/doi.org\/10.1159\/000081365","journal-title":"Fetal Diagn Ther"},{"issue":"8","key":"2350_CR99","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/pd.1780","volume":"27","author":"Y Purwosunu","year":"2007","unstructured":"Purwosunu Y, Sekizawa A, Farina A, Wibowo N, Okazaki S, Nakamura M, Samura O, Fujito N, Okai T (2007) Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 27(8):772\u2013777. https:\/\/doi.org\/10.1002\/pd.1780","journal-title":"Prenat Diagn"},{"issue":"12","key":"2350_CR100","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.placenta.2010.09.011","volume":"31","author":"L Avila","year":"2010","unstructured":"Avila L, Yuen RK, Diego-Alvarez D, Penaherrera MS, Jiang R, Robinson WP (2010) Evaluating DNA methylation and gene expression variability in the human term placenta. Placenta 31(12):1070\u20131077. https:\/\/doi.org\/10.1016\/j.placenta.2010.09.011","journal-title":"Placenta"},{"issue":"1","key":"2350_CR101","first-page":"9","volume":"55","author":"N Fujito","year":"2006","unstructured":"Fujito N, Samura O, Miharu N, Tanigawa M, Hyodo M, Kudo Y (2006) Increased plasma mRNAs of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia. Hiroshima J Med Sci 55(1):9\u201315","journal-title":"Hiroshima J Med Sci"},{"issue":"4","key":"2350_CR102","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1447-0756.2010.01349.x","volume":"37","author":"M Kodama","year":"2011","unstructured":"Kodama M, Miyoshi H, Fujito N, Samura O, Kudo Y (2011) Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia. J Obstet Gynaecol Res 37(4):313\u2013318. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01349.x","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"2350_CR103","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5603\/GP.a2018.0025","volume":"89","author":"MC Ibanoglu","year":"2018","unstructured":"Ibanoglu MC, Ozgu-Erdinc AS, Uygur D (2018) Maternal placi protein levels in early- and late-onset preeclampsia. Ginekol Pol 89(3):147\u2013152. https:\/\/doi.org\/10.5603\/GP.a2018.0025","journal-title":"Ginekol Pol"},{"issue":"4","key":"2350_CR104","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.placenta.2013.01.006","volume":"34","author":"M Matteo","year":"2013","unstructured":"Matteo M, Greco P, Levi Setti PE, Morenghi E, De Rosario F, Massenzio F, Albani E, Totaro P, Liso A (2013) Preliminary evidence for high anti-PLAC1 antibody levels in infertile patients with repeated unexplained implantation failure. Placenta 34(4):335\u2013339. https:\/\/doi.org\/10.1016\/j.placenta.2013.01.006","journal-title":"Placenta"},{"key":"2350_CR105","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2017-0019","author":"A Liso","year":"2017","unstructured":"Liso A, Massenzio F, Stracci F (2017) PLAC1 immunization does not induce infertility in mice. Immunotherapy. https:\/\/doi.org\/10.2217\/imt-2017-0019","journal-title":"Immunotherapy"},{"key":"2350_CR106","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5402\/2011\/530491","volume":"2011","author":"AC Kotto-Kome","year":"2011","unstructured":"Kotto-Kome AC, Silva C, Whiteman V, Kong X, Fant ME (2011) Circulating anti-PLAC1 antibodies during pregnancy and in women with reproductive failure: a preliminary analysis. ISRN Immunol 2011:5. https:\/\/doi.org\/10.5402\/2011\/530491","journal-title":"ISRN Immunol"},{"issue":"4","key":"2350_CR107","first-page":"5924","volume":"15","author":"Q Li","year":"2018","unstructured":"Li Q, Liu M, Wu M, Zhou X, Wang S, Hu Y, Wang Y, He Y, Zeng X, Chen J (2018) PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer. Oncol Lett 15(4):5924\u20135932","journal-title":"Oncol Lett"},{"issue":"10","key":"2350_CR108","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1158\/1078-0432.CCR-10-2939","volume":"17","author":"TM Cardillo","year":"2011","unstructured":"Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Goldenberg DM (2011) Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res 17(10):3157\u20133169","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2350_CR109","first-page":"2","volume":"7","author":"AA Bayat","year":"2015","unstructured":"Bayat AA, Ghods R, Shabani M, Mahmoudi AR, Yeganeh O, Hassannia H, Sadeghitabar A, Balay-Goli L, Noutash-Haghighat F, Reza Sarrafzadeh A (2015) Production and characterization of monoclonal antibodies against human prostate specific antigen. Avicenna J Med Biotechnol 7(1):2","journal-title":"Avicenna J Med Biotechnol"},{"issue":"5","key":"2350_CR110","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1021\/acs.bioconjchem.5b00223","volume":"26","author":"TM Cardillo","year":"2015","unstructured":"Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Arrojo R, Chang C-H, Liu D, Rossi EA, Goldenberg DM (2015) Sacituzumab govitecan (IMMU-132), an anti-Trop-2\/SN-38 antibody\u2013drug conjugate: characterization and efficacy in pancreatic, gastric, and other cancers. Bioconjug Chem 26(5):919\u2013931","journal-title":"Bioconjug Chem"},{"issue":"1","key":"2350_CR111","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/ar700108g","volume":"41","author":"RVJ Chari","year":"2008","unstructured":"Chari RVJ (2008) Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 41(1):98\u2013107","journal-title":"Acc Chem Res"},{"issue":"10","key":"2350_CR112","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","volume":"65","author":"R Van der Meel","year":"2013","unstructured":"Van der Meel R, Vehmeijer LJC, Kok RJ, Storm G, Van Gaal EVB (2013) Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev 65(10):1284\u20131298","journal-title":"Adv Drug Deliv Rev"},{"key":"2350_CR113","doi-asserted-by":"crossref","unstructured":"Xiao Z, Jackson D, Tice DA (2013) EphA2 immunoconjugate. In: Phillips GL (ed) Antibody-drug conjugates and immunotoxins: from pre-clinical development to therapeutic applications, 1st edn. Springer, New York, pp 241\u2013253","DOI":"10.1007\/978-1-4614-5456-4_14"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-019-02350-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:34:00Z","timestamp":1721363640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-019-02350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02350-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}